» Articles » PMID: 19028365

Autoinflammatory Diseases

Overview
Publisher Elsevier
Specialty Rheumatology
Date 2008 Nov 26
PMID 19028365
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Autoinflammatory diseases (AIDs) are illnesses caused by primary dysfunction of the innate immune system. Proteins that are mutated in AIDs mediate the regulation of NFkappaB activation, cell apoptosis, and IL-1beta secretion through cross-regulated and sometimes common signaling pathways. AIDs include a broad number of monogenic [e.g., familial Mediterranean fever (FMF), cryopyrin-associated periodic syndrome (CAPS), mevalonate kinase deficiency (MKD), tumor necrosis factor (TNF)-receptor-associated periodic syndrome (TRAPS)] and multifactorial (e.g., Behçet's syndrome) disorders. These conditions are characterized by recurrent attacks of fever, abdominal pain, arthritis, and cutaneous signs; these symptoms sometimes overlap, obscuring diagnosis. Distinguishing signs and the use of specific functional tests where available (e.g., in MKD) are helpful. However, some patients remain hard to manage despite the advent of new genetic tests and/or due to lack of effective treatment.

Citing Articles

The Potential Role of Cell-Death Mechanisms in the Pathogenesis of Familial Mediterranean Fever Attacks: Granzyme A and Beyond.

Yaglikara E, Boluk O, Bayindir Y, Bilginer Y, Tasar M, Ozen S Diagnostics (Basel). 2024; 14(18).

PMID: 39335710 PMC: 11431255. DOI: 10.3390/diagnostics14182031.


Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature.

Liu J, Zhang R, Yi Z, Lin Y, Chang H, Zhang Q Pediatr Rheumatol Online J. 2023; 21(1):15.

PMID: 36765385 PMC: 9918341. DOI: 10.1186/s12969-023-00795-x.


Liver immunity, autoimmunity, and inborn errors of immunity.

Parlar Y, Ayar S, Cagdas D, Balaban Y World J Hepatol. 2023; 15(1):52-67.

PMID: 36744162 PMC: 9896502. DOI: 10.4254/wjh.v15.i1.52.


Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.

Mohammadnezhad L, Shekarkar Azgomi M, La Manna M, Sireci G, Rizzo C, Badami G Cells. 2022; 11(10).

PMID: 35626700 PMC: 9140143. DOI: 10.3390/cells11101663.


Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.

Matsumoto Y, Dimitriou I, La Rose J, Lim M, Camilleri S, Law N J Clin Invest. 2022; 132(7).

PMID: 35362478 PMC: 8970677. DOI: 10.1172/JCI140869.